Why Is TARSUS PHARMACEUTICA (TARS) Stock Moving Today?

TARS stock is moving lower today, down 0.24% to $56.12, as the stock continues to trade in a bearish trend amid recent insider selling and a revised price target from Guggenheim. The stock opened with a 0.8% gap up at $56.70 but quickly reversed direction, hitting a session low of $55.24 before stabilizing near $56.12. The session has seen no volume so far, with no trades reported.

What Happened

Guggenheim cut the price target for Tarsus Pharmaceuticals to $89, a reduction from a previous level. This move comes amid a broader backdrop of insider selling, with multiple executives and board members, including CEO Bobak R. Azamian, selling shares in recent days. The stock has been under pressure for weeks, with a 30-day average sentiment score of 53 out of 100 and a recent 7-day average of 34, indicating deteriorating market confidence. The stock is also trading below its 52-week high of $85.25 and has declined 8.2% over the past eight sessions.

What The Data Shows

The stock opened with a small gap up but has since trended lower, reflecting ongoing bearish momentum. With no volume reported and a 0.50 beta, the stock is less volatile than the broader market but remains sensitive to sentiment shifts. Tarsus Pharmaceuticals has a market cap of $2.6 billion, with unprofitable fundamentals, a net margin of -9.0%, and a recent revenue increase of 129.0% year to date. The stock is currently trading near the lower end of its 52-week range and has seen four insider sales totaling $2.5 million in the last 90 days.

What To Watch

Investors should monitor the stock for unusual options activity or further insider transactions. No earnings date is scheduled in the immediate future, but coverage breadth remains limited with only one story in the last 36 hours.